Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations-Reference-Cited by-同舟云学术

Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations

Published:2012-06-30 Issue:1 Volume:9 Page:25-30
ISSN:1226-1769
Container-title:Journal of Genetic Medicine
language:en
Short-container-title:J Genet Med

Author:

Hong Woo Sung¹,Kim Ku Sang¹,Jung Yong Sik¹,Kang Seok Yun²,Kang Doo Kyoung³,Kim Tae Hee³,Yim Hyunee⁴,Chun Mison⁵,Park Myong Chul⁶,Chang Suk-Joon⁷

Affiliation:

1. Departments of Surgery, Ajou University School of Medicine, Suwon, Korea

2. Departments of Hematology - Oncology, Ajou University School of Medicine, Suwon, Korea

3. Departments of Radiology, Ajou University School of Medicine, Suwon, Korea

4. Departments of Pathology, Ajou University School of Medicine, Suwon, Korea

5. Departments of Radiation Oncology, Ajou University School of Medicine, Suwon, Korea

6. Departments of Plastic and econstructive Surgery, Ajou University School of Medicine, Suwon, Korea

7. Departments of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea

Publisher

Korean Society of Medical Genetics

Subject

General Medicine

Link

http://pdf.medrang.co.kr/JGM/2012/009/JGM-9-025.pdf

Reference17 articles.

1. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

2. Decision Analysis of Prophylactic Surgery or Screening for BRCA1 Mutation Carriers: A More Prominent Role For Oophorectomy

3. Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, et al. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis. Cancer J Sci Am 2000;6:13-20.

4. Contralateral Prophylactic Mastectomy and Prophylactic Salphingo-Oophorectomy in a BRCA1-Positive Breast Cancer Patient: A Case Report

5. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations